HUP0402510A3 - Nociceptin analogs and pharmaceutical compositions containing them - Google Patents
Nociceptin analogs and pharmaceutical compositions containing themInfo
- Publication number
- HUP0402510A3 HUP0402510A3 HU0402510A HUP0402510A HUP0402510A3 HU P0402510 A3 HUP0402510 A3 HU P0402510A3 HU 0402510 A HU0402510 A HU 0402510A HU P0402510 A HUP0402510 A HU P0402510A HU P0402510 A3 HUP0402510 A3 HU P0402510A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- nociceptin
- analogs
- nociceptin analogs
- Prior art date
Links
- PULGYDLMFSFVBL-SMFNREODSA-N nociceptin Chemical class C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 PULGYDLMFSFVBL-SMFNREODSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28467601P | 2001-04-18 | 2001-04-18 | |
| US28467401P | 2001-04-18 | 2001-04-18 | |
| PCT/US2002/012356 WO2002085291A2 (en) | 2001-04-18 | 2002-04-18 | Nociceptin analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0402510A2 HUP0402510A2 (hu) | 2005-04-28 |
| HUP0402510A3 true HUP0402510A3 (en) | 2012-08-28 |
Family
ID=26962736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0402510A HUP0402510A3 (en) | 2001-04-18 | 2002-04-18 | Nociceptin analogs and pharmaceutical compositions containing them |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US6861421B2 (hu) |
| EP (2) | EP1379252A4 (hu) |
| JP (2) | JP4380992B2 (hu) |
| KR (3) | KR100855204B1 (hu) |
| CN (1) | CN100441182C (hu) |
| AU (2) | AU2002303406B2 (hu) |
| BR (1) | BR0209128A (hu) |
| CA (1) | CA2444108C (hu) |
| HK (1) | HK1070573A1 (hu) |
| HU (1) | HUP0402510A3 (hu) |
| IL (2) | IL158486A0 (hu) |
| MX (1) | MXPA03009602A (hu) |
| RU (1) | RU2268883C2 (hu) |
| WO (1) | WO2002085291A2 (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA007272B1 (ru) * | 2002-03-13 | 2006-08-25 | Янссен Фармацевтика Н. В. | Новые ингибиторы гистондеацетилазы |
| US7566728B2 (en) | 2002-03-29 | 2009-07-28 | Mitsubishi Tanabe Pharma Corporation | Remedy for sleep disturbance |
| US7718652B2 (en) | 2006-12-12 | 2010-05-18 | Wyeth Llc | Substituted benzothiadiazinedioxide derivatives and methods of their use |
| CL2007003590A1 (es) * | 2006-12-12 | 2008-02-29 | Wyeth Corp | Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt |
| RS51474B (en) * | 2007-01-16 | 2011-04-30 | Purdue Pharma L.P. | HETEROCYCLICALLY SUBSTITUTED PIPERIDINES AS ORL-1 LIGANDS |
| BRPI0815327A2 (pt) * | 2007-08-31 | 2015-12-15 | Purdue Pharma Lp | "compostos de piperidina do tipo quinoxalina substituída e os usos destes" |
| RU2500678C2 (ru) | 2008-07-21 | 2013-12-10 | Пэдью Фарма Л.П. | Замещенные хиноксалинового типа мостиковые пиперидиновые соединения и их применение |
| JP5872585B2 (ja) * | 2010-12-22 | 2016-03-01 | パーデュー、ファーマ、リミテッド、パートナーシップ | リン置換キノキサリンタイプピペリジン化合物とその使用 |
| WO2014102590A1 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Substituted piperidin-4-amino-type compounds and uses thereof |
| US9963458B2 (en) | 2012-12-27 | 2018-05-08 | Purdue Pharma L.P. | Indole and indoline-type piperidine compounds and uses thereof |
| US9951038B2 (en) | 2012-12-27 | 2018-04-24 | Purdue Pharma L.P. | Quinazolin-4(3H)-one-type piperidine compounds and uses thereof |
| US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
| JP6359560B2 (ja) * | 2012-12-31 | 2018-07-18 | サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | 複素環式化合物及びその使用方法 |
| RS60315B1 (sr) | 2016-01-13 | 2020-07-31 | Gruenenthal Gmbh | Derivati 3-((hetero-)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana |
| RS60855B1 (sr) | 2016-01-13 | 2020-10-30 | Gruenenthal Gmbh | Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana |
| EP3402781B1 (en) | 2016-01-13 | 2020-03-04 | Grünenthal GmbH | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
| KR20180100592A (ko) | 2016-01-13 | 2018-09-11 | 그뤼넨탈 게엠베하 | 3-(카복시에틸)-8-아미노-2-옥소-1,3-디아자-스피로-[4.5]-데칸 유도체 |
| SI3402785T1 (sl) | 2016-01-13 | 2020-07-31 | Gruenenthal Gmbh | Derivati 3-(karboksimetil)-8-amino-2-okso-1,3-diaza-spiro-(4.5)-dekana |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3161645A (en) | 1962-12-18 | 1964-12-15 | Res Lab Dr C Janssen N V | 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds |
| US3318900A (en) | 1964-05-06 | 1967-05-09 | Janssen Pharmaceutica Nv | Derivatives of benzimidazolinyl piperidine |
| US3325499A (en) | 1964-11-02 | 1967-06-13 | Mcneilab Inc | 1-(1-hydrocarbyl-4-piperdyl)-2-indolinone |
| DE2609645A1 (de) | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
| DE3066434D1 (en) * | 1979-11-21 | 1984-03-08 | Kyowa Hakko Kogyo Kk | Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them |
| US4344945A (en) * | 1980-03-10 | 1982-08-17 | Kyowa Hakko Kogyo Co., Ltd. | Piperidine derivatives |
| US4329353A (en) | 1980-10-22 | 1982-05-11 | Janssen Pharmaceutica, N.V. | 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof |
| US4410528A (en) | 1980-05-16 | 1983-10-18 | Kyowa Hakko Kogyo Co., Ltd. | Hypotensive piperidine derivatives |
| JPS5759889A (en) * | 1980-09-30 | 1982-04-10 | Kyowa Hakko Kogyo Co Ltd | Novel piperidine derivative |
| JPS58180481A (ja) | 1982-04-15 | 1983-10-21 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体 |
| JPS60120872A (ja) * | 1983-12-01 | 1985-06-28 | Kyowa Hakko Kogyo Co Ltd | 新規なヘテロ環状化合物及び強心剤 |
| EP0382185B1 (en) * | 1989-02-10 | 1994-06-15 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| WO1995019773A1 (en) * | 1992-10-07 | 1995-07-27 | Merck & Co., Inc. | Carbostyril oxytocin receptor antagonists |
| ATE216580T1 (de) * | 1993-07-16 | 2002-05-15 | Merck & Co Inc | Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten |
| EP0755392A4 (en) * | 1994-04-14 | 1997-05-02 | Merck & Co Inc | ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS |
| FR2722190B1 (fr) | 1994-07-05 | 1996-10-04 | Sanofi Sa | Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant |
| US5767118A (en) * | 1994-10-26 | 1998-06-16 | Merck & Co., Inc. | 4-Heterocyclic peperidines promote release of growth hormone |
| US5574044A (en) | 1994-10-27 | 1996-11-12 | Merck & Co., Inc. | Muscarine antagonists |
| DE69635048T2 (de) | 1995-06-12 | 2006-02-16 | G.D. Searle & Co. | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
| ATE218126T1 (de) | 1995-09-13 | 2002-06-15 | Kyowa Hakko Kogyo Kk | Phenylpiperidin-derivate |
| EP0898568B1 (en) | 1996-04-19 | 2006-10-04 | Neurosearch A/S | 1-(4-piperidyl)-benzimidazoles having neurotrophic activity |
| US6063796A (en) * | 1997-04-04 | 2000-05-16 | Merck & Co., Inc. | Somatostatin agonists |
| KR20010020172A (ko) | 1997-05-30 | 2001-03-15 | 나가사까 겐지로 | 2-옥소이미다졸 유도체 |
| JPH10330377A (ja) * | 1997-06-02 | 1998-12-15 | Kyowa Hakko Kogyo Co Ltd | ピペリジン誘導体 |
| US6166037A (en) | 1997-08-28 | 2000-12-26 | Merck & Co., Inc. | Pyrrolidine and piperidine modulators of chemokine receptor activity |
| SI0921125T1 (en) | 1997-12-05 | 2002-04-30 | F. Hoffmann-La Roche Ag | 1,3,8-Triazaspiro(4,5)decan-4-on derivatives |
| US6166209A (en) | 1997-12-11 | 2000-12-26 | Hoffmann-La Roche Inc. | Piperidine derivatives |
| DK1049689T3 (da) | 1998-01-19 | 2002-07-22 | Pfizer | 4-(2-keto-1-benzimidazolinyl)piperidinderivater som ORL1-receptoragonister |
| RU2202344C2 (ru) | 1998-03-26 | 2003-04-20 | Джапан Тобакко Инк. | Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции |
| AU3809999A (en) | 1998-05-18 | 1999-12-06 | Novo Nordisk A/S | Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| ID29137A (id) | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
| MA26659A1 (fr) | 1998-08-06 | 2004-12-20 | Pfizer | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. |
| JP2001044213A (ja) * | 1999-07-30 | 2001-02-16 | Hitachi Cable Ltd | ヘテロバイポーラトランジスタ用エピタキシャルウエハ |
| SE9904652D0 (sv) * | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
| DE60112725T2 (de) | 2000-02-18 | 2006-06-01 | Meiji Seika Kaisha Ltd. | Phenoxyalkylaminderivate als agonisten des opioid-delta rezeptors |
| AU8645401A (en) * | 2000-08-14 | 2002-02-25 | Ortho Mcneil Pharm Inc | Substituted pyrazoles |
| EP1315490B1 (en) * | 2000-09-06 | 2008-11-12 | Ortho-McNeil Pharmaceutical, Inc. | A method for treating allergies using substituted pyrazoles |
| JP2007009500A (ja) * | 2005-06-30 | 2007-01-18 | Nissei Ltd | パズル循環式駐車設備の運転方法 |
-
2002
- 2002-04-18 KR KR1020067024260A patent/KR100855204B1/ko not_active IP Right Cessation
- 2002-04-18 MX MXPA03009602A patent/MXPA03009602A/es active IP Right Grant
- 2002-04-18 EP EP02731427A patent/EP1379252A4/en not_active Withdrawn
- 2002-04-18 WO PCT/US2002/012356 patent/WO2002085291A2/en active Application Filing
- 2002-04-18 HU HU0402510A patent/HUP0402510A3/hu unknown
- 2002-04-18 EP EP08015057A patent/EP1997818A3/en not_active Withdrawn
- 2002-04-18 CA CA2444108A patent/CA2444108C/en not_active Expired - Fee Related
- 2002-04-18 RU RU2003133454/04A patent/RU2268883C2/ru not_active IP Right Cessation
- 2002-04-18 CN CNB028121686A patent/CN100441182C/zh not_active Expired - Fee Related
- 2002-04-18 AU AU2002303406A patent/AU2002303406B2/en not_active Ceased
- 2002-04-18 JP JP2002582867A patent/JP4380992B2/ja not_active Expired - Fee Related
- 2002-04-18 IL IL15848602A patent/IL158486A0/xx unknown
- 2002-04-18 KR KR1020037013695A patent/KR100729242B1/ko not_active IP Right Cessation
- 2002-04-18 KR KR1020057022594A patent/KR100722207B1/ko not_active IP Right Cessation
- 2002-04-18 US US10/126,507 patent/US6861421B2/en not_active Expired - Lifetime
- 2002-04-18 BR BR0209128-3A patent/BR0209128A/pt not_active Application Discontinuation
-
2003
- 2003-10-19 IL IL158486A patent/IL158486A/en not_active IP Right Cessation
-
2005
- 2005-03-01 US US11/069,728 patent/US7563809B2/en not_active Expired - Fee Related
- 2005-04-15 HK HK05103227.4A patent/HK1070573A1/xx not_active IP Right Cessation
-
2006
- 2006-06-30 AU AU2006202794A patent/AU2006202794A1/en not_active Abandoned
-
2009
- 2009-06-16 US US12/485,612 patent/US20090253727A1/en not_active Abandoned
- 2009-07-24 JP JP2009173441A patent/JP2009280603A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401109A3 (en) | Nociceptin analogs, their use and pharmaceutical compositions containing them | |
| HUP0303325A3 (en) | Pharmaceutical salts and pharmaceutical compositions containing them | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| EP1407785A4 (en) | MEDICAL COMPOSITIONS | |
| SI1381346T1 (sl) | Farmacevtski sestavki, ki vsebujejo formoterol | |
| IL187604A0 (en) | Pharmaceutical compositions containing an interleukin-6 antagonist | |
| HK1065944A1 (en) | Medicinal compositions | |
| PL367180A1 (en) | Stabilized oral pharmaceutical composition | |
| HUP0400974A3 (en) | Peptide-based compounds and pharmaceutical compositions containing them | |
| GB0319041D0 (en) | Pharmaceutical Formulations | |
| HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
| IL159532A0 (en) | Enteral formulations | |
| IL150447A0 (en) | Pharmaceutical compositions containing entecavir | |
| GB0111597D0 (en) | Pharmaceutical compositions | |
| HUP0400245A3 (en) | Somatostatin-dopamine chimeric analogs and pharmaceutical compositions containing them | |
| HUP0402510A3 (en) | Nociceptin analogs and pharmaceutical compositions containing them | |
| HUP0400850A3 (en) | Oral pharmaceutical compositions | |
| HUP0400077A2 (hu) | Deutériumozott 3-piperidino-propiofenon és a vegyületeket tartalmazó gyógyszerekészítmények | |
| HUP0500638A2 (en) | Flashmelt oral dosage formulation | |
| HUP0401733A3 (en) | Cyclic amine-derivatives and pharmaceutical compositions containing them | |
| GB0103638D0 (en) | Pharmaceutical formulations | |
| GB0120701D0 (en) | Pharmaceutical formulations | |
| GB0121715D0 (en) | Pharmaceutical formulations | |
| GB0203527D0 (en) | Pharmaceutical formulations | |
| GB0105560D0 (en) | Pharmaceutical formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |